Sponsor Pipeline

Iksuda Therapeutics Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
9
Disease Areas
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT05365659
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas		 Primary endpoint(s) modified
2026-07-30 NCT05365659
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas		 date change Primary completion pushed: 2026-09 -> 2027-09
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-31 NCT07738939 IKS04 Regimen in Advanced Solid Tumors That Express CA242 Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT05872295 IKS014 in Advanced Solid Tumors That Express HER2 Breast Cancer Recruiting
NCT05365659 IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas B-cell Non-Hodgkin Lymphoma Recruiting
NCT07738939 IKS04 Regimen in Advanced Solid Tumors That Express CA242 Colorectal Cancer Not Yet Recruiting
Disease Areas
Gastric Cancer (2) Non-Hodgkin Lymphoma (1) Follicular Lymphoma (1) Mantle Cell Lymphoma (1) Breast Cancer (1) Colorectal Cancer (1) Pancreatic Cancer (1) Bladder Cancer (1) Cholangiocarcinoma (1)
Get alerts when Iksuda Therapeutics Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free